1 / 15

Quality Workshop Copenhagen – January 2012

Quality Workshop Copenhagen – January 2012. Training session Outline and Objectives. Outline. General talks : Update on Prequalification of Medicines Programme ICH quality guidances: an overview. Outline. Active Pharmaceutical Ingredient (API) talks:

kkathy
Download Presentation

Quality Workshop Copenhagen – January 2012

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Quality WorkshopCopenhagen – January 2012 Training session Outline and Objectives

  2. Outline General talks: Update on Prequalification of Medicines Programme ICH quality guidances: an overview

  3. Outline Active Pharmaceutical Ingredient (API) talks: Options for submitting API data API assessment: common deficiencies Assessing specifications: API Stability evaluation: API

  4. Outline Finished Pharmaceutical Product (FPP) talks: Manufacturing basics and issues: solid orals FPP assessment: common deficiencies Assessing specifications: FPP Stability assessment: FPP

  5. Outline Special talks: Packaging and labelling – quality and WHOPAR Regulatory capacity building and NDRA approvals of prequalified products (Training and TA) Bioequivalence – general considerations and Q&A Biobatch considerations for the quality assessment

  6. Breakout sessions begin. Be prepared with your questions!

  7. Objectives General objectives Increase knowledgeof key quality areas: specification, stability, general areas of deficiency. One-on-one feedback: provides a forum for individual questions to be answered by a senior assessor. Make note of any and all questions re PQP and quality assessment as they occur to you.

  8. Objectives Providing insight into some commonly encountered deficiencies and how to deal with them. Provide an interactive forum for exchanging knowledge. Exam on Saturday will help us find out how best to tailor future workshops. (closed book)

  9. Acronyms! Al: aluminum API: active pharmaceutical ingredient ARV: antiretroviral AV: acceptance value BCS: biopharmaceutics classification system BE: bioequivalence BP: British Pharmacopoeia BW: biowaiver COA: certificate of analysis CQA: critical quality attribute CU: content uniformity

  10. Acronyms! DSV: dose solubility volume DT: disintegration EMA: (formerly EMEA) European Medicines Agency EP: European Pharmacopoeia EPAR: European public assessment report EtOH: ethanol FDC: fixed-dose combination FDA: Food and Drug Administration (U.S.) FPP: finished pharmaceutical product GC: gas chromatography GMP: good manufacturing practices

  11. Acronyms! HC: Health Canada HPLC: high performance (or pressure) liquid chromatography ICH: International Conference on Harmonization IPC: in-process controls IR: infrared spectroscopy IT: identification threshold JP: Japanese Pharmacopoeia KF: Karl Fischer LOD: limit of detection OR loss on drying LOQ: limit of quantitation MeOH: methanol

  12. Acronyms! mg: milligrams MP: mobile phase MS: mass spectrometry MU: mass uniformity NLT/NMT: not less/more than ORP: officially recognized compendia PDG: Pharmacopoeial Discussion Group PhInt: International Pharmacopoeia PIL: patient information leaflet ppm: parts per million PQP: Prequalification of Medicines Programme

  13. Acronyms! PSD: particle size distribution QIS: quality information summary QT: qualification threshold ROI: residue on ignition RSD: relative standard deviation R specs: release specifications RT: retention time S1: stage 1 S2: supplement 2 SmPC: summary of product characteristics SOQR: summary of quality review

  14. Acronyms! S specs: shelf-life/stability specifications SST: system suitability testing SUPAC: scale-up and post approval changes TB: tuberculosis TLC: thin layer chromatography TRS: technical report series USP: United States Pharmacopeia WHOPAR: WHO public assessment report w.r.t.: with respect to XRD: x-ray diffraction

More Related